
Vensica Medical
Vensica Medical develops breakthrough urology therapeutics using ultrasound drug delivery for localized treatment of bladder conditions.
About
Vensica Medical is a medical device company focused on urology therapeutics. They have developed Vibe®, an innovative ultrasound drug delivery technology, and ViXe, which integrates Xeomin® (an FDA-approved neurotoxin) with this technology for localized treatment of overactive bladder and other bladder conditions. Their approach aims to improve efficacy and reduce side effects compared to systemic drug delivery.
Key facts
- Website
- vensica.com
- Headquarters
- Tel Aviv, Israel
- Founded
- 2014
- Employees
- 10
- Total funding
- $31M
- Valuation
- Private
- Business model
- B2B
- Tags
- HealthcareUrologyDrug DeliveryMedTechUltrasound Technology
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 29 Oct 2024 | Undisclosed round | $11M | Israel Biotech Fund |
| 1 Mar 2022 | Series B | $20M | Israel Biotech Fund |
Tech stack
Detected on vensica.com, last scanned 12 Sept 2026. Run your own scan
- Email provider
- Microsoft 365
Add first review
Frequently asked
How much funding has Vensica Medical raised?
Vensica Medical has raised a total of $31M in funding.
How many employees does Vensica Medical have?
Vensica Medical has approximately 10 people on record.
